PAHC
NASDAQ · Pharmaceuticals
Phibro Animal Health Corp-A
$54.89
+1.71 (+3.22%)
Performance
1D
—
1W
—
1M
—
3M
+5.86%
6M
+21.09%
1Y
+124.04%
YTD
+47.16%
Open$53.30
Previous Close$53.18
Day High$56.06
Day Low$52.59
52W High$60.08
52W Low$19.00
Volume—
Avg Volume414.0K
Market Cap1.67B
P/E Ratio18.13
EPS$2.26
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$42.00
Above
SMA 200
$35.40
Above
RSI (14)
80.2
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
9 analysts
Price Target
+96.2% upside
Current
$54.89
$54.89
Target
$107.71
$107.71
$71.95
$107.71 avg
$157.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 969.21M | 871.51M | 1.31B |
| Net Income | 36.09M | 29.21M | 335.32M |
| Profit Margin | 3.7% | 3.5% | 25.7% |
| EBITDA | 116.70M | 99.69M | 482.41M |
| Free Cash Flow | — | — | 282.39M |
| Rev Growth | +11.2% | +11.2% | +2.9% |
| Debt/Equity | 2.52 | 2.52 | 0.38 |
Dividend
Dividend Yield1.11%
Annual Dividend$0.48
Payout Ratio40.3%
Frequencyquarterly
Ex-DividendApr 7, 2026
Pay DateApr 17, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |